SCHEMBL1863433

SCHEMBL1863433

CC1(C)CCC(CN2CCN(c3ccc(C(=O)N[S+]([O-])c4ccc(NC5CCN(CC(F)(F)F)CC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1

nearest known ligand 0.83

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 20/20 0.83

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1870981 0.93 BCL2 (0.74) BCL2
SCHEMBL27075547 0.92 BCL2 (0.83) BCL2
SCHEMBL1699879 0.91 BCL2 (1.00) BCL2
SCHEMBL30314006 0.91 BCL2 (1.00) BCL2
SCHEMBL1861888 0.90 BCL2 (0.81) BCL2
SCHEMBL19292332 0.88 BCL2 (0.83) BCL2
SCHEMBL21573216 0.87 BCL2 (0.73) BCL2
SCHEMBL1871704 0.86 BCL2 (0.83) BCL2
SCHEMBL1869537 0.86 BCL2 (0.76) BCL2
SCHEMBL1867507 0.85 BCL2 (0.87) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010138588-A9 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBOTT LABORATORIES (US) 2011-05-05 — — WO disclosed
Send feedback